Cinco, Joan .
HRN: 23-64-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
METRONIDAZOLE 500MG (TAB)
08/31/2023
09/07/2023
PO
500mg Tab
TID
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes